Ratnakar Securities Pvt. Ltd.

FDC LTD.

NSE : FDCBSE : 531599ISIN CODE : INE258B01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE457.70-11.45 (-2.44 %)

PREV CLOSE ( ) 469.15

OPEN PRICE ( ) 467.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7219

TODAY'S LOW / HIGH ( )455.10 470.75

52 WK LOW / HIGH ( )358.95 659

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 23-09 1940

Management Info

Uday Kumar Gurkar - Chairman Mohan A Chandavarkar - Managing Director

Registered Office

Address B-8,Midc Industrial Area,Waluj Dist,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431136

Phone 0240- 2554407 / 2554967 / 2554299

Email waluj@fdcindia.com

Website www.fdcindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

17Jun Clarification On Spurt In Volume
Please find attached clarification in response to letter no. L/SURV/ONL/..

29May FDC informs about press release
FDC has attached the Press Release issued in relation to the Audited Sta..

22May FDC informs about board meeting
FDC has informed that the meeting of the Board of Directors of the Compa..

12May FDC recalling 60,428 bottles of Timolo
FDC is recalling 60,428 bottles of Timolol Maleate Ophthalmic Solution,..

14Apr FDC informs about compliances certific
FDC has enclosed Certificate issued by the Registrar and Share Transfer..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	482.15	2736.25
Gross Profit	675.41	3676.71
Operating Profit	842.52	4257.65
Net Sales	4820.04	20701.12

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RPG Life Sciences (BSE) 2417.50 (6.95%)	M.Cap ( in Cr)3932.15
TTK Healthcare (BSE) 1287.50 (3.06%)	M.Cap ( in Cr)1807.62
Dr. Reddy's Lab (BSE) 1326.40 (1.04%)	M.Cap ( in Cr)110330.30
Biocon (BSE) 348.60 (1.89%)	M.Cap ( in Cr)41894.94
Brooks Laboratories (BSE) 133.00 (4.72%)	M.Cap ( in Cr)388.84

Shareholding Pattern

	PROMOTERS	69.66%
	MUTUAL FUNDS/UTI	6.18%
	NON-INSTITUTION	21.42%
	FI/BANKS/INSURANCE	0.07%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata India Pharma &...	1.57
ICICI Pru ESG Exclu...	1.54
ITI Pharma & Health...	1.44
ICICI Pru MNC Fund(G)	1.20
ICICI Pru Pharma He...	0.96
ICICI Pru Smallcap ...	0.89

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

FDC LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES